共 50 条
- [1] The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer's Disease Taking Cholinesterase InhibitorsCNS DRUGS, 2013, 27 (06) : 469 - 478Grossberg, George T.Manes, FacundoAllegri, Ricardo F.Miguel Gutierrez-Robledo, LuisGloger, SergioXie, LeiJia, X. DanielPejovic, VojislavMiller, Michael L.Perhach, James L.Graham, Stephen M.
- [2] Benefits of Extended-Release Memantine (28 Mg, Once Daily) on Caregiver Distress: Results of a Multinational, Double-Blind, Placebo-Controlled Trial in Moderate to Severe Alzheimer's DiseaseAMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (03): : S73 - S74Grossberg, George T.Manes, FacundoAllegri, RicardoGutierrez Robledo, Luis MiguelGloger, SergioXie, LeiJia, Xinwei D.Perhach, James L.Tocco, MichaelGraham, Stephen M.
- [3] Benefits of Extended-Release Memantine (28 mg, Once Daily) on Caregiver Distress: Results of a Multinational, Double-Blind, Placebo-Controlled Trial in Moderate to Severe Alzheimer's DiseaseNEUROLOGY, 2010, 74 (09) : A271 - A271Grossberg, GeorgeManes, FacundoAllegri, RicardoGutierrez Robledo, Luis MiguelGloger, SergioXie, LeiJia, Xinwei DanielPerhach, James L.Tocco, MichaelGraham, Stephen
- [4] A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's diseaseINTERNATIONAL PSYCHOGERIATRICS, 2013, 25 (06) : 919 - 927Herrmann, NathanGauthier, SergeBoneva, NeliLemming, Ole Michael
- [5] Extended-release Memantine (28 mg, once daily) Improves Verbal Fluency and Behavior in Patients with Moderate to Severe Alzheimer's Disease: Results of a Multinational, Double-blind, Placebo-controlled TrialAMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A78 - A78Grossberg, George T.Manes, FacundoAllegri, RicardoGutierrez Robledo, Luis MiguelGloger, SergioXie, LeiJia, X. DanielPerhach, James L.Graham, Stephen M.
- [6] Extended-Release Memantine (28 mg, Once Daily) Improves Verbal Fluency and Behavior in Patients with Moderate to Severe Alzheimer's Disease: Results of a Multinational, Double-Blind, Placebo-Controlled TrialNEUROLOGY, 2009, 72 (11) : A384 - A385Grossberg, GeorgeManes, FacundoAllegri, RicardoMiguel, LuisRobledo, GutierrezGloger, SergioXie, LeiJia, DanielPerhach, JamesGraham, Stephen M.
- [7] A multinational, randomized, double-blind, placebo-controlled trial of memantine extended-release capsule in patients with moderate to severe Alzheimer's diseaseANNALS OF NEUROLOGY, 2008, 64 : S41 - S42Grossberg, George T.Manes, FacundoAllegri, RicardoRobledo, Luis Miguel GutierrezGloger, SergioXie, LeiJia, Xinwei DanielPerhach, JamesGraham, Stephen M.
- [8] Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's diseaseINTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (03) : 258 - 262Jones, Roy W.Bayer, AntonyInglis, FraserBarker, AndrewPhul, Ravinder
- [9] Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in JapanEXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 913 - 925Nakamura, YuKitamura, ShinHomma, AkiraShiosakai, KazuhitoMatsui, Daiju
- [10] Efficacy and safety of once-daily carvedilol in patients with atrial fibrillation: A randomized, double-blind, placebo-controlled trialHEART RHYTHM, 2024, 21 (10) : 2051 - 2052Choi, Jong-IlPark, Yae MinOh, Yong-SeogKim, Jin-BaeHan, SeongwookPark, Jong-SungOn, Young KeunChoi, Kee-JoonHwang, Gyo-SeungLee, Moon-HyoungShin, Dong-GuKim, Nam-HoKim, Dae-KyeongNamgung, JuneKim, Dae-HyeokPark, Hyung-WookPark, Hwan-CheolChoi, Eue-KeunRhee, Kyoung SukShin, Seung YongKim, Young-Hoon